Accure Therapeutics
Spain - BarcelonaBiotechnology
Focus: Accure Therapeutics is a Barcelona-based biotech founded in 2020 focused on neuro treatments in ophthalmology, currently in early-stage clinical development with a single Phase 1 program.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
5-2 this month
Stable — net -2 jobs in 30d
1 added, 3 removed. Backfill posture.
Should You Work at Accure Therapeutics?
AI assessmentAccure is a high-risk early-stage bet suitable only for founders-minded biotech specialists willing to weather clinical attrition and potential acquirer integration.
Why Work Here
- Early-stage opportunity to shape drug development strategy in an underserved neuro-ophthalmology space with BN201 targeting optic neuritis
- Balanced hiring across Commercial (3 roles) and IT (3 roles) suggests infrastructure investment despite pre-revenue stage
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
BN201
Optic NeuritisClinical Trials (1)
NCT03630497BN201 SAD MAD Study in Healthy Subjects
Phase 1Help build intelligence for Accure Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.